PGM3 Monoclonal Antibody
-
中文名稱:PGM3 Monoclonal Antibody
-
貨號:CSB-MA998074
-
規格:¥1320
-
圖片:
-
其他:
產品詳情
-
產品名稱:Mouse anti-Homo sapiens (Human) PGM3 Monoclonal antibody
-
Uniprot No.:
-
基因名:PGM3
-
別名:PGM3; Phosphoglucomutase 3; AGM1; PAGM; Acetylglucosamine Phosphomutase; Phosphoacetylglucosamine Mutase; DKFZP434B187; EC 5.4.2.3; PGM 3; N-Acetylglucosamine-Phosphate Mutase 1; N-Acetylglucosamine-Phosphate Mutase; Phosphoglucomutase-3; EC 5.4.2; IMD23
-
宿主:Mouse
-
反應種屬:Human, Rat
-
免疫原:Recombinant Human PGM3 protein
-
免疫原種屬:Homo sapiens (Human)
-
標記方式:Non-conjugated
-
克隆類型:Monoclonal
-
抗體亞型:Mouse IgG1
-
純化方式:Affinity-chromatography
-
克隆號:21C6
-
濃度:It differs from different batches. Please contact us to confirm it.
-
保存緩沖液:PBS (pH 7.4) containing 50% glycerol, and 0.02% sodium azide.
-
產品提供形式:Liquid
-
應用范圍:ELISA, WB
-
推薦稀釋比:
Application Recommended Dilution WB 1:500-1:2500 -
Protocols:
-
儲存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關產品
靶點詳情
-
功能:Catalyzes the conversion of GlcNAc-6-P into GlcNAc-1-P during the synthesis of uridine diphosphate/UDP-GlcNAc, a sugar nucleotide critical to multiple glycosylation pathways including protein N- and O-glycosylation.
-
基因功能參考文獻:
- Novel PGM3 Mutation Is Associated With a Severe Phenotype of Bone Marrow Failure, Severe Combined Immunodeficiency, Skeletal Dysplasia, and Congenital Malformations. PMID: 28543917
- study reports the first founder mutation in PGM3 gene (p.Glu340del) in twelve Tunisian PGM3 deficient patients belonging to three consanguineous families originating from a rural district in west central Tunisia PMID: 28704707
- PGM3 mutation identified in a patient with hyper IgE syndrome results in lack of glycosylation at Asn264 and altered glycosylation profile. PMID: 26687240
- Data indicate the effect of the phosphoglucomutase 3 (PGM3) mutation for four immunodeficient siblings in a Swedish family. PMID: 26482871
- define PGM3-CDG as a treatable immunodeficiency, document the power of whole-exome sequencing in gene discoveries for rare disorders, and illustrate the utility of genomic analyses in studying combined and variable phenotypes PMID: 24931394
- Impairment of PGM3 function leads to a novel primary (inborn) error of development and immunity because biallelic hypomorphic mutations are associated with impaired glycosylation and a hyper-IgE-like phenotype. PMID: 24698316
- Autosomal recessive hypomorphic PGM3 mutations underlie a disorder of severe atopy, immune deficiency, autoimmunity, intellectual disability, and hypomyelination. PMID: 24589341
- Polymorphic analysis of the human phosphoglucomutase-3 gene. PMID: 20221814
- PGM(3) is identical to AGM(1). PMID: 12174217
顯示更多
收起更多
-
相關疾病:Immunodeficiency 23 (IMD23)
-
蛋白家族:Phosphohexose mutase family
-
組織特異性:Found in many tissues except lung. Relatively high expression in pancreas, heart, liver, and placenta, and relatively low expression in brain, skeletal muscle and kidney.
-
數據庫鏈接:
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-















